A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan

MLA

Yasushi Goto, Md, PhD, et al. “A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan.” JTO Clinical and Research Reports, vol. 4, no. 5, May 2023. EBSCOhost, https://doi.org/10.1016/j.jtocrr.2023.100508.

APA

Yasushi Goto, M., PhD, Hirotsugu Kenmotsu, M., PhD, Motohiro Tamiya, M., Shuji Murakami, M., Takayasu Kurata, M., Noriko Yanagitani, M., Hirokazu Taniguchi, M., PhD, Shoichi Kuyama, M., PhD, Junichi Shimizu, M., PhD, Toshihide Yokoyama, M., Naoko Shimada, M., PhD, Tadashi Maeda, M., Akihiro Tamiya, M., Ayumi Uchiyama, M., Kazuyoshi Imaizumi, M., Takayuki Takahama, M., PhD, Terufumi Kato, M., Hidetoshi Hayashi, M., PhD, Naoko Shiraiwa, Ms., … Makoto Nishio, M., PhD. (2023). A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan. JTO Clinical and Research Reports, 4(5). https://doi.org/10.1016/j.jtocrr.2023.100508

Chicago

Yasushi Goto, Md, PhD, Md Hirotsugu Kenmotsu PhD, Md Motohiro Tamiya, Md Shuji Murakami, Md Takayasu Kurata, Md Noriko Yanagitani, Md Hirokazu Taniguchi PhD, et al. 2023. “A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan.” JTO Clinical and Research Reports 4 (5). doi:10.1016/j.jtocrr.2023.100508.